Schedule 13G ownership disclosure
CONSTELLATION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 210373106
Event date: 2019-10-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-266785
- Form type
- SC 13G
- Filer
- Bain Capital Life Sciences Fund, L.P.
- CIK
- CIK 1687968
- Filed
- Oct 11, 2019
- Reporting period
- Oct 01, 2019
- Description
- Schedule 13G beneficial ownership